MLMiranda van Lunteren

Miranda van Lunteren

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Miranda van Lunteren has a total of 112 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Which instrument measuring structural damage progression in axial SpA is most sensitive to change? Results from the SPondyloArthritis Caught Early cohort

    by Liese J E de Bruin, Floris A van Gaalen, Manouk de Hooge, Miranda van Lunteren, Mary Lucy Marques, Monique Reijnierse, Roberta Ramonda, Inger Jorid Berg, Sofia Exarchou, Robert Landewé, et al.

  • Ten-year Longitudinal Relationship between Spinal Degenerative Lesions in Axial Spondyloarthritis at MRI and Radiography in the DESIR Cohort

    by Laura Pina Vegas, Floris van Gaalen, Miranda van Lunteren, Damien Loeuille, Caroline Morizot, Esther Newsum, Pascal Claudepierre, Alain Saraux, Antoine Feydy, Monique Reijnierse, et al.

    Ten-year longitudinal imaging analyses demonstrated the sequential development of spinal degenerative lesions at MRI and radiography at the same and adjacent vertebral levels, clarifying their temporal relationships and progression.

  • MRI structural lesions in axSpA: distinguishing outcome measures from diagnostic thresholds

    by Sofia Ramiro, Floris A. van Gaalen, Manouk de Hooge, Miranda van Lunteren, Désirée van der Heijde, Robert Landewé


  • Relationship between spinal lesions related to axial spondyloarthritis and degenerative spinal lesions: 10-year follow-up of the DESIR cohort

    by Laura Pina Vegas, Floris Alexander van Gaalen, Miranda van Lunteren, Damien Loeuille, Caroline Morizot, Esther Newsum, Pascal Claudepierre, Alain Saraux, Antoine Feydy, Monique Reijnierse, et al.

    Objective: This study aimed to investigate the relationship between spinal axial spondyloarthritis (axSpA)-related lesions and degenerative lesions (DLs) over 10 years (10Y). Methods: Whole spine MRI and cervical/lumbar spine radiographs at baseline/5Y/10Y from patients with axSpA from the DESIR cohort were assessed for axSpA-related lesions and DLs by three independent readers, different teams for the two lesion types. We used multilevel (patient and vertebra, considering consensus across readers), standard and time-lagged autoregressive generalized estimating equation (GEE) models. The relationship between syndesmophytes and the subsequent development of osteophytes/syndesmophytes in adjacent vertebrae on radiographs was analysed using a time-lagged autoregressive GEE model, after excluding vertebrae with both lesions. All models were adjusted for age, sex, HLA-B27 status, BMI, smoking and job type, and bDMARDs during follow-up. Results: Data from 326 patients (35 [S.D. = 9] years; 46% men) showed a significant association between axSpA-related lesions on MRI and the total number of DLs on MRI, though the effect sizes were small (β-coefficients: 0.07–0.17). On radiographs, paravertebral syndesmophytes were significantly associated with the total number of DLs (β-coefficient: 0.37; 95%CI: 0.26–0.48). However, these associations were not found in time-lagged autoregressive models. Syndesmophytes increased the risk of adjacent syndesmophyte [odds ratio (OR):6.92; 95%CI: 2.44–19.61], but not of osteophytes (OR: 1.05; 95%CI: 0.25–4.36). Conclusion: Although significant associations were found between axSpA-related lesions and DLs at the same time point, no temporal relationship was observed. On radiographs, syndesmophytes increased the risk of syndesmophytes at adjacent levels, but there was no association with osteophyte development. AxSpA-related lesions and DLs coexist, but progress independently of each other.


  • Open Access

    Reducing selection bias while maintaining precision through an integrated analysis: 2-year longitudinal analysis of imaging outcomes in the SPondyloArthritis Caught Early cohort

    by Liese J E de Bruin, Floris A van Gaalen, Manouk de Hooge, Miranda van Lunteren, Mary Lucy Marques, Monique Reijnierse, Roberta Ramonda, Inger Jorid Berg, Carl Turesson, Robert Landewé, et al.

    Background: Cohort studies often use simple models, for example, completers-only or aggregated scores, to assess changes in imaging outcomes. With more data available, this introduces selection bias. Integrated analyses allow scores from multiple reading rounds; therefore, we assessed their effect on the change estimates’ precision compared with the completers-only analysis. Second, we compared change estimates from models using aggregated scores and scores analysed per reader. Methods: Patients with axial spondyloarthritis (axSpA) from the SPondyloArthritis Caught Early cohort were followed for 2 years. Imaging of the sacroiliac joints and spine was scored by ≥2 central readers in two rounds. Change in imaging outcomes was analysed using generalised estimating equations, with different patient and data selections for integrated and completers-only analyses. The integrated and multilevel completers-only analyses assessed outcomes per reader. Change estimates of the completers-only analysis of aggregated scores of readers were compared with estimates of the multilevel completers-only analysis. Results: The integrated analysis included 332 patients (vs 279 completers-only). Compared with the multilevel completers-only analysis, the integrated analysis included 12%–16% more patients with a similar precision. Within the completers-only population, change estimates from models using reader and aggregated scores were similar for continuous outcomes. However, similar comparisons in dichotomous outcomes showed that models with aggregated scores underestimated spinal changes (maximum 82% less) and overestimated sacroiliac joint changes (maximum 37% more). Conclusion: Multilevel models retain level variability by integrating information across patients, time points, readers and rounds to reduce selection bias and improve precision of change, which would otherwise be lost in simpler models.


  • Open Access

    Which definitions for MRI sacroiliac joint lesions predict the diagnosis of early axial spondyloarthritis best? A 2-year follow-up in the SPACE cohort

    by Liese J E de Bruin, Mary Lucy Marques, Miranda van Lunteren, Manouk de Hooge, Monique Reijnierse, Sofia Exarchou, Inger Jorid Berg, Roberta Ramonda, Robert Landewé, Floris A van Gaalen, et al.

    Background: The Leiden group and the Assessment of Spondyloarthritis International Society (ASAS)-MRI study group have proposed definitions for structural (SL) and active (AL) lesions typical for axial spondyloarthritis (axSpA) on MRI of the sacroiliac joints (MRI-SIJ). Objectives: To analyse the predictive validity of proposed SL and AL MRI-SIJ definitions in early axSpA and compare proposed AL with the current ASAS-MRI-SIJ+ definition. Methods: Patients with chronic back pain (≤2 years) from the Spondyloarthritis Caught Early cohort were diagnosed as axSpA or non-axSpA after 2 years follow-up. Three central readers scored baseline MRI-SIJ for SL (erosions and fat lesions) and AL (bone marrow oedema). Validation required specificity and positive predictive value (PPV) ≥95%. Results: Among 643 patients (52% axSpA), SL were infrequent (2%–14%). All Leiden and most MRI study group SL definitions met the validation threshold, except for ‘erosion in ≥2 consecutive slices’ and the overall MRI study group definition (PPV <95%). The ASAS-MRI-SIJ+ definition had a higher sensitivity than the MRI study group AL (40% vs 31%) with similar specificity (98% vs 99%). Combining SL and AL, the Leiden SL with ASAS-MRI-SIJ+ definition met the validation threshold with the highest sensitivity (46%). SL increased sensitivity beyond AL alone by 6%–11%. Conclusions: The ASAS-MRI-SIJ+ definition outperforms the MRI study group AL. The Leiden SL combined with the ASAS-MRI-SIJ+ definition is validated, most sensitive and feasible as it simultaneously upholds lesion quantification and detection precision, making it the preferred approach. Nevertheless, SL were uncommon in early axSpA, contributing only marginally beyond AL definitions in early diagnosis.


  • How calculating consensus change scores can go wrong: lessons from multireader imaging assessments in axial spondyloarthritis

    by Ana Bento da Silva, Sofia Ramiro, Floris van Gaalen, Robert Landewé, Miranda van Lunteren, Liese de Bruin, Gizem Ayan, Xenofon Baraliakos, Monique Reijnierse, Jürgen Braun, et al.


  • Open Access

    Differences in spinal structural lesions between patients with early axSpA and non-axSpA chronic back pain: 2-year SPACE cohort results

    by Gizem Ayan, Liese de Bruin, Miranda van Lunteren, Manouk de Hooge, Ana Bento da Silva, Mary Lucy Marques, Monique Reijnierse, Victoria Navarro-Compán, Marleen van de Sande, Inger Jorid Berg, et al.

    Objectives: To compare spinal structural lesions on radiography and magnetic resonance imaging (MRI) over 2 years, between patients with early axial spondyloarthritis (axSpA) and non-axSpA chronic back pain. Methods: Patients from the SPACE cohort with available radiography or MRI at both baseline and 2years were included. Spinal lesions on radiography were assessed by the modified Stoke Ankylosing Spondylitis Spine Score (mSASSS), corner MRI lesions by the modified Canada–Denmark scoring system. Baseline spinal structural lesions and 2-year changes were compared between axSpA and non-axSpA. Generalized estimating equations were used to assess the change over 2 years, adjusting for age, sex, non-steroidal anti-inflammatory drug use and diagnosis. Results: Radiography data from 318 patients (67% axSpA), MRI data from 351 patients (69% axSpA) were included. At baseline, the mean (SD) mSASSS was 0.6 (1.1) for both axSpA and non-axSpA. Over 2 years, mSASSS progression was minimal (0.01 units/year) in both groups. On MRI, axSpA patients had a mean of 1.4 (2.9) total structural lesions compared with 0.7 (2) in non-axSpA at baseline (P = 0.12). Significant 2-year increase in structural lesions [0.5 (1.8)] was mainly due to fat lesions [0.5 (1.6)] in axSpA. On MRI, fat lesions changed at a rate of 0.16 units/year in axSpA (P = 0.002) and −0.02 units/year in non-axSpA (P = 0.70). Conclusion: Over 2 years, spinal structural damage typical for axSpA progressed minimally on radiography in axSpA and non-axSpA. On MRI, axSpA showed a significant increase in fat lesions, while non-axSpA had no progression. Fat lesions may be important to assess spinal changes from early disease onwards.


  • Open Access

    Baseline and 2-year differences in spinal symptoms and spinal and hip mobility in early axial spondyloarthritis and non-axial spondyloarthritis chronic back pain patients

    by Ana Bento da Silva, Sofia Ramiro, Miranda van Lunteren, Mary Lucy Marques, Marleen van de Sande, Camilla Fongen, Sofia Exarchou, Roberta Ramonda, Désirée van der Heijde, Floris A van Gaalen

    Objective To compare spinal symptoms and spinal/hip mobility at baseline and 2 years in early axial spondyloarthritis (axSpA) and non-axSpA chronic back pain (BP) patients. Methods Baseline and 2 years data of the SPondyloarthritis Caught Early cohort were analysed. Outcomes assessed: overall BP, BP at night, morning stiffness (MS) intensity, MS duration, occiput-to-wall distance (OWD), cervical rotation, chest expansion, lateral spinal flexion (LSF), modified Schober test (mSchober), intermalleolar distance (IMD) and Bath Ankylosing Spondylitis Metrology Index (BASMI). Linear or zero-inflated negative binomial regression was used to compare 2 years outcomes between groups (adjusting for baseline value, sex, age and use of non-steroidal anti-inflammatory drugs). Results There were 294 axSpA and 123 non-axSpA patients (mean symptom duration: 13 months). At baseline, non-axSpA patients had worse symptoms and mobility, except OWD (eg, mean(SD): BP at night 3.6 (2.9) axSpA vs 4.6 (2.7) non-axSpA; OWD 0.5 (1.2) vs 0.1 (0.7)). After 2 years, all symptoms and cervical rotation significantly improved in both groups, but LSF and mSchober only in axSpA. In multivariable analyses, axSpA was associated with larger improvements in BP at night (β (95% CI): −0.85 (−1.47; −0.23)), mSchober (0.26 (0.03; 0.50)), IMD (4.86 (1.93; 7.80)) and BASMI (−0.24 (−0.41; −0.08)), and with lower likelihood of a normal OWD (OR (95% CI): 0.09 (0.01; 0.83)). Conclusion Over 2 years, all spinal symptoms and some mobility measures improved in both groups, but impairments remained prevalent (particularly in non-axSpA). Nevertheless, axSpA was associated with larger improvements in BP at night, mSchober, IMD and BASMI, but with more OWD impairment.


  • Open Access

    Change in different classes of chronic back pain suspicious of axial spondyloarthritis: a latent transition analysis of the SPACE cohort

    by Philipp Bosch, Alexandre Sepriano, Mary-Lucy Marques, Désirée van der Heijde, Robert Landewé, Miranda van Lunteren, Liese de Bruin, Manouk de Hooge, Caroline Bastiaenen, Sofia Exarchou, et al.

    Objectives To follow up four previously identified classes ‘pure axial spondyloarthritis’ (axSpA) (‘axial’), ‘axSpA with peripheral signs’ (‘inflammatory back pain+peripheral’), ‘axSpA at risk’ and ‘no spondyloarthritis’ (‘no SpA’). They reflect the expert-opinion-free construct or ‘Gestalt’ of chronic back pain suspicious of axSpA. The aim was to assess participants’ transitions between these classes over time. Methods Participants with chronic back pain of ≤2 years duration, suspicious of axSpA from the SPondyloArthritis Caught Early cohort were analysed. Latent class (LCA) and latent transition analysis (LTA) using clinical, laboratory and imaging data at baseline and 2 years were calculated. Conditional and marginal probabilities were obtained, reflecting the probability of a spondyloarthritis feature in a class and the probability of the participant’s class membership, respectively. Transitional probabilities were extracted revealing potential switches across classes. The analyses were performed in all participants using imputations for missing data and in participants with full data at baseline and 2 years. Results Baseline and 2 years LCA models were constructed for 702 participants, resulting in the same four-class model as previously described. LTA revealed only a 3% transition from the ‘no SpA’ to the ‘at-risk’ class from baseline to 2 years with all other participants remaining in their initially assigned class. Sensitivity analysis on 384 participants with complete data at both baseline and 2 years showed similar results, underlining the model’s robustness. Conclusions Transitions between the four classes over 2 years were basically inexistent, highlighting the unlikelihood of developing new class-defining features of axSpA after an initial clinical workup.